Ms Dongqing Chen
University of Newcastle, Newcastle (Australia)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
The clinically active PARP inhibitor olaparib ameliorates doxorubicin-induced cardiotoxicity in both in vitro and in vivo model
Event: ESC Congress 2023
Topic: Drugs, Drug Targets
Session: Molecular cardio-oncology
Doxorubicin-induced upregulation of follistatin-like 3 (FSTL3): a new therapeutic target
Event: ESC Congress 2022
Topic: Drugs, Drug Targets
Session: Acquired forms of heart failure: cancer and inflammatory disorders
Follistatin-like 3 (FSTL3) levels are increased in acute heart failure patients
Event: ESC Congress 2021 - The Digital Experience
Topic: Biomarkers
Session: Acute heart failure e-posters
ESC 365 is supported by
